首页> 外文OA文献 >An observational, multicentre study of cabazitaxel in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (CAPRISTANA)

【2h】

An observational, multicentre study of cabazitaxel in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (CAPRISTANA)

机译：在先前用多紫杉醇（Capristana）治疗的转移阉割抗阉割前列腺癌患者的患者的观察到。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Joan Carles; Angelika Pichler; Hana Korunkova; Antoaneta Tomova; Marwan Ghosn; Fadi El Karak; Joseph Makdessi; Irina Koroleva; Gisoo Barnes; Denise Bury; Ayse Özatilgan; Simon Hitier; Jana Katolicka;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. An observational, multicentre study of cabazitaxel in patients with metastatic castration‐resistant prostate cancer previously treated with docetaxel ( CAPRISTANA CAPRISTANA ) [J] . Carles Joan, Pichler Angelika, Korunkova Hana, BJU international . 2019,第3期

机译：在先前用多西紫杉醇（Capristana Capristana）治疗的转移阉割抗阉割前列腺癌患者中的观察到.Cabazitaxel
2. Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial [J] . Beer Tomasz M., Hotte Sebastien J., Saad Fred, The lancet oncology . 2017,第11期

机译：Custirsen（OGX-011）与Cabazitaxel和Prednisone与Cabazitaxel和Prednisone一起联合出来的转移阉割阉割前列腺癌患者（亲和力）：随机，开放标签，国际，第3阶段试验
3. Efficacy and safety of abiraterone acetate plus prednisone vs. cabazitaxel as a subsequent treatment after first-line docetaxel in metastatic castration-resistant prostate cancer: results from a prospective observational study (CAPRO) [J] . Javier Puente, Aranzazu González-del-Alba, Núria Sala-Gonzalez, BMC Cancer . 2019,第1期

机译：AbiraTerone醋酸盐加上泼尼松与Cabazitaxel的疗效和安全性作为后续治疗转移阉割前列腺癌中的后续治疗：结果来自前瞻性观察研究（Capro）
4. Metastatic Hormone-Sensitive and Castration-Resistant Prostate Cancer: A Decade of Progress and Ongoing Discoveries [C] . Leonel Hernez-Aya, Maha Hussain Genitourinary Cancers Symposium. . 2014

机译：转移激素敏感和阉割的前列腺癌：进步和持续发现的十年
5. Muscle Cross-Sectional Area Is Improved and Physical Funciton Is Maintained After Home-Based Exercise in Men with Metastatic Castration-Resistant Prostate Cancer Undergoing Androgen Deprivation Therapy [D] . Alzer, Mohamdod Saber. 2020

机译：改善肌横截面积，并且在具有转移阉割的前列腺癌接受雄激素剥夺治疗的男性中的男性锻炼之后，将物理静脉凝集维持
6. Statin use and survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: the international retrospective observational STABEN study [O] . Jacob A. Gordon, Carlo Buonerba, Gregory Pond, 2018

机译：多西他赛治疗失败后用阿比特龙或恩杂鲁胺治疗转移性去势抵抗性前列腺癌患者的他汀类药物使用和生存：国际回顾性STABEN研究
7. PD14-11 HEALTH-RELATED QUALITY OF LIFE (HRQL) IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) TREATED WITH CABAZITAXEL (CBZ) IN A PROSPECTIVE OBSERVATIONAL STUDY (CAPRISTANA) [O] . Angelika Pichler, Gisoo Barnes, Jana Katolicka, 2018

机译：PD14-11与前瞻性观察研究（Capristaana）在Cabazitaxel（CBZ）治疗的转移阉割抗阉割前列腺癌（MCRPC）患者中有关的寿命寿命（HRQ1）

An observational, multicentre study of cabazitaxel in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (CAPRISTANA)

著录项

引文网络

相似文献

相关主题

期刊订阅